Original title: A National Survey Exploring Dementia Diagnostics and Care Provisions in Primary Care in England
Ayoni Darby, Jasmine Shaw, Claudia Cooper, Natalia Chemas +6 · September 2026
England plans to shift healthcare from hospitals into local communities. Soon, new dementia blood tests and disease-modifying treatments will arrive. These new tools could heavily impact general practitioners, who are local family doctors. Researchers wanted to know how ready these clinics are for these changes. They surveyed family doctors to see how they currently diagnose dementia and what they expect to handle in the future. Today, almost every surveyed doctor uses thinking tests and blood tests to spot dementia, but fewer can order brain scans directly. When looking ahead five years, most doctors doubt they will personally confirm formal dementia diagnoses or check if patients qualify for the new treatments. However, a majority believe they could realistically offer new blood biomarker tests and handle ongoing monitoring or prescribing for patients already taking the treatments. Doctors warned that a lack of resources, time, and training stand in the way.
Imagine you are a supply teacher handed a class for a day. You have the register, but no notes on which students struggle, and no time to find out. You can keep the class busy, but you cannot give the extra help some students need. Here, family doctors are the supply teachers: they are the first people families turn to about memory problems, but they lack the time, training and staff to take on the new tests and treatments planned for dementia care.
England's 10 Year Health Plan wants to move dementia care out of hospitals and into the community, and new biomarker tests and disease-modifying treatments are on the way. But GPs are the first point of contact, and most say they won't be formally diagnosing dementia or assessing who qualifies for those treatments within five years. Without more time, staff and training, the people who need these advances may not get them.
The abstract does not state a formal limitations section, but the 7.3% response rate and recruitment from five ICBs mean results may not generalise to all of England. It also captures GPs' expectations rather than actual future practice or patient outcomes.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
A National Survey Exploring Dementia Diagnostics and Care Provisions in Primary Care in England — Ayoni Darby, Jasmine Shaw, Claudia Cooper et al. — medRxiv — doi:10.64898/2026.09.11.26362825
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper. This is a preprint, so it hasn't necessarily been peer reviewed.